Scholars Central

Conference abstractPublished 17 Oct 2016

Checkpoint blockade in hematology and stem cell transplantation

Authors: Saad Kenderian

Mayo Clinic, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Blockade of the immune checkpoints has recently emerged as a paradigm shift in the treatment of solid tumors. Several programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibitors are now approved and are moving to first line therapy in several solid tumors. Other checkpoint blocking agents are in earlier phases of development. These inhibitors have also been investigated in the treatment of hematological malignancies, with significant and durable response rates in Hodgkin Lymphoma. PD-1 inhibitors are also active in non-Hodgkin lymphoma but responses are lower than what is observed in Hodgkin lymphoma. Therefore, several strategies are being employed to enhance the activity of checkpoint blocking agents, such as combination with monoclonal antibodies, other immune modulatory agents or stem cell transplantation. Here, we will review the activity and safety of checkpoint blockade in lymphoma and leukemia and strategies used to enhance their activity. Then, we’ll discuss how we see these therapies being applied in the context of bone marrow transplantation and adoptive T cell therapy.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Hematology & Thromboembolic Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hematology & Thromboembolic Diseases
  • SubjectHaematology
  • BylineArticles whose byline prints “Saad Kenderian”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels